4.7 Article

Polymeric micelles for MCL-1 gene silencing in breast tumors following systemic administration

期刊

NANOMEDICINE
卷 11, 期 17, 页码 2319-2339

出版社

FUTURE MEDICINE LTD
DOI: 10.2217/nnm-2016-0178

关键词

cancer; cholesterol; MCL-1; MDA-MB-435; PEO-b-PCL; polymeric micelles; RGD4C; siRNA delivery; spermine

资金

  1. Canadian Institute of health Research (CIHR) [MOP 137153]
  2. Alberta Innovates Health Solutions (AIHS)
  3. ACF
  4. JN Tata Trust

向作者/读者索取更多资源

Aim: To develop delivery systems for efficient siRNA delivery to breast cancer. Methods: Poly(ethylene oxide)-block-poly(e-caprolactone-grafted-spermine) (PEO-b-P(CL-g-SP)) micelles were modified with cholesterol group in their core and with RGD4C peptide on their shell. Transfection efficiency of complexed MCL-1 siRNA in MDA-MB-435 was investigated, in vitro and in vivo following intratumoral and intravenous injection. Results: Cholesteryl modification of the core significantly increased the transfection efficiency of PEO-b-P(CL-g-SP)-complexed siRNA, in vitro, but not following intratumoral or intravenous administration, in vivo. Instead, RGD4C modification of the micellar shell enhanced transfection efficiency of complexed MCL1 siRNA in tumor upon intravenous administration. Conclusion: RGD4C-PEO-b-P(CL-gSP) micelles, without or with cholesterol modification, can provide efficient delivery of siRNA to breast tumors following systemic administration.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据